Alpine Global Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$160 Hold
20,000
﹤0.01% 226
2025
Q4
$948 Hold
20,000
﹤0.01% 340
2025
Q3
$2.19K Hold
20,000
﹤0.01% 211
2025
Q2
$1.32K Hold
20,000
﹤0.01% 161
2025
Q1
$4.2K Sell
20,000
-20,000
-50% -$4.48K ﹤0.01% 128
2024
Q4
$6.4K Buy
40,000
+20,000
+100% +$3.44K ﹤0.01% 210
2024
Q3
$1.48K Hold
20,000
﹤0.01% 159
2024
Q2
$594 Hold
20,000
﹤0.01% 461
2024
Q1
$1.1K Hold
20,000
﹤0.01% 198
2023
Q4
$238 Hold
20,000
﹤0.01% 189
2023
Q3
$598 Hold
20,000
﹤0.01% 156
2023
Q2
$142 Hold
20,000
﹤0.01% 203
2023
Q1
$370 Hold
20,000
﹤0.01% 132
2022
Q4
$0 Hold
20,000
﹤0.01% 543
2022
Q3
$4K Sell
20,000
-800
-4% -$225 ﹤0.01% 274
2022
Q2
$7K Sell
20,800
-19,200
-48% -$7.83K ﹤0.01% 304
2022
Q1
$28 Hold
40,000
0.01% 344
2021
Q4
$39K Buy
40,000
+50
+0.1% +$98 0.01% 712
2021
Q3
$85K Buy
39,950
+19,950
+100% +$65.6K 0.02% 260
2021
Q2
$92K Hold
20,000
0.01% 268
2021
Q1
$101K Buy
+20,000
New +$111K 0.01% 283

Other funds holding WGSWW

Alpine Global Management's WGSWW Position: Q1 2026 in Review

Alpine Global Management held its GeneDx Holdings Warrant (WGSWW) position steady in Q1 2026 at 20,000 shares worth $160. The position accounts for ﹤0.01% of the portfolio, ranked #226.

Alpine Global Management first reported a position in WGSWW in Q1 2021 and has held it in 21 quarters since. The position peaked at $101K in Q1 2021. 13 funds tracked by Wall St. Rank hold WGSWW as of Q1 2026.

  • Alpine Global Management held 20,000 shares of GeneDx Holdings Warrant worth $160 as of Q1 2026.
  • Alpine Global Management left its GeneDx Holdings Warrant share count unchanged in Q1 2026.
  • GeneDx Holdings Warrant made up ﹤0.01% of Alpine Global Management's portfolio in Q1 2026, its #226 holding.
  • Alpine Global Management first reported a position in GeneDx Holdings Warrant in Q1 2021 and has held it in 21 quarters since.
  • Alpine Global Management's GeneDx Holdings Warrant position peaked at $101K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2026.

Based on Alpine Global Management's 13F filing for Q1 2026, filed 15 May 2026.